{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:14:26Z","timestamp":1789892066611,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000011","name":"HHMI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI167966"],"award-info":[{"award-number":["P01AI167966"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["DP1AI158186"],"award-info":[{"award-number":["DP1AI158186"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93022C00036"],"award-info":[{"award-number":["75N93022C00036"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.celrep.2024.114530","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T21:20:56Z","timestamp":1721856056000},"page":"114530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans"],"prefix":"10.1016","volume":"43","author":[{"given":"Amin","family":"Addetia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin R.","family":"Sprouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayed Y.","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Al-Mozaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Memish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer N.","family":"Alshukairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-8675","authenticated-orcid":false,"given":"David","family":"Veesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.114530_bib1","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.114530_bib2","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2024.114530_bib3","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.114530_bib4","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.40.20290-en","article-title":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012","volume":"17","author":"Bermingham","year":"2012","journal-title":"Euro Surveill."},{"key":"10.1016\/j.celrep.2024.114530_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.114530_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101191","article-title":"MERS-CoV Confirmation among 6,873 suspected persons and relevant Epidemiologic and Clinical Features, Saudi Arabia \u2014 2014 to 2019","volume":"41","author":"Ebrahim","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.celrep.2024.114530_bib8","series-title":"Disease Outbreak News","article-title":"Middle East Respiratory Syndrome Coronavirus - Kingdom of Saudi Arabia","year":"2024"},{"key":"10.1016\/j.celrep.2024.114530_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.celrep.2024.114530_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01985-18","article-title":"High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia","volume":"9","author":"Alshukairi","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2024.114530_bib11","article-title":"MERS-CoV spillover at the camel-human interface","volume":"7","author":"Dudas","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2024.114530_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib13","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1073\/pnas.1407087111","article-title":"Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein","volume":"111","author":"Millet","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114530_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","article-title":"Structural insights into coronavirus entry","volume":"105","author":"Tortorici","year":"2019","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.celrep.2024.114530_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2024.114530_bib17","doi-asserted-by":"crossref","first-page":"E8508","DOI":"10.1073\/pnas.1712592114","article-title":"Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114530_bib18","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41594-019-0334-7","article-title":"Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors","volume":"26","author":"Park","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2024.114530_bib19","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114530_bib20","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1073\/pnas.1608147113","article-title":"Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism","volume":"113","author":"Park","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114530_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006546","article-title":"The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases","volume":"13","author":"Earnest","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2024.114530_bib22","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114530_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/22221751.2019.1597644","article-title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein","volume":"8","author":"Widjaja","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.celrep.2024.114530_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan5393","article-title":"Recovery from the Middle East respiratory syndrome is associated with antibody and T\u00a0cell responses","volume":"2","author":"Zhao","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.114530_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","article-title":"Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial","volume":"20","author":"Koch","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2024.114530_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","article-title":"Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","volume":"20","author":"Folegatti","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2024.114530_bib27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","article-title":"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","volume":"19","author":"Modjarrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2024.114530_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib29","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114530_bib30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","article-title":"Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion","volume":"176","author":"Walls","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114530_bib31","article-title":"Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.celrep.2024.114530_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.celrep.2018.06.041","article-title":"Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114530_bib33","doi-asserted-by":"crossref","first-page":"234ra59","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.114530_bib34","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2024.114530_bib35","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1038\/s41467-019-10897-4","article-title":"Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114530_bib36","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114530_bib37","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114530_bib38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41564-022-01155-3","article-title":"Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2","volume":"7","author":"Sun","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2024.114530_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83710","article-title":"Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses","volume":"12","author":"Silva","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2024.114530_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41594-021-00596-4","article-title":"Structural basis for broad coronavirus neutralization","volume":"28","author":"Sauer","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2024.114530_bib41","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix\u2013specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114530_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg5567","article-title":"A\u00a0MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus","volume":"15","author":"Tse","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.114530_bib43","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.celrep.2019.08.052","article-title":"Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114530_bib44","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114530_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.114530_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf1421","article-title":"SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines","volume":"7","author":"Bowen","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.114530_bib47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2024.114530_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010592","article-title":"The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes","volume":"18","author":"Greaney","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2024.114530_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010248","article-title":"A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy","volume":"18","author":"Greaney","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2024.114530_bib50","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3201\/eid2705.204056","article-title":"Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia","volume":"27","author":"Alshukairi","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2024.114530_bib51","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmi.2021.06.009","article-title":"Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study","volume":"28","author":"Cheon","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.celrep.2024.114530_bib52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3201\/eid2307.170310","article-title":"MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015","volume":"23","author":"Choe","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2024.114530_bib53","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3201\/eid2112.151421","article-title":"Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea","volume":"21","author":"Park","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2024.114530_bib54","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3201\/eid2210.160706","article-title":"Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus","volume":"22","author":"Payne","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2024.114530_bib55","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3390\/v14081743","article-title":"Outbreak of Middle East Respiratory Syndrome Coronavirus in Camels and Probable Spillover Infection to Humans in Kenya","volume":"14","author":"Ngere","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.celrep.2024.114530_bib56","doi-asserted-by":"crossref","first-page":"e016511-16","DOI":"10.1128\/JVI.01651-16","article-title":"Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants","volume":"91","author":"Tai","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2024.114530_bib57","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41598-022-05318-4","article-title":"The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections","volume":"12","author":"Jang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2024.114530_bib58","doi-asserted-by":"crossref","first-page":"e013811-18","DOI":"10.1128\/JVI.01381-18","article-title":"Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization","volume":"93","author":"Kleine-Weber","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2024.114530_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00019-16","article-title":"Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak","volume":"7","author":"Kim","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2024.114530_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102983118","article-title":"Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence","volume":"118","author":"Wong","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114530_bib61","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.cell.2023.01.019","article-title":"A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114530_bib62","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.abe3354","article-title":"Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms","volume":"370","author":"Tortorici","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114530_bib63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/infdis\/jiaa618","article-title":"Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"223","author":"Crawford","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2024.114530_bib64","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.abi7994","article-title":"SARS-CoV-2 immune evasion by the B.1.427\/B.1.429 variant of\u00a0concern","volume":"373","author":"McCallum","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114530_bib65","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.abl8506","article-title":"Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants","volume":"374","author":"McCallum","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114530_bib66","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114530_bib67","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114530_bib68","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.cell.2021.09.015","article-title":"Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines","volume":"184","author":"Walls","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114530_bib69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib70","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib71","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abq2679","article-title":"ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies","volume":"377","author":"Low","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114530_bib72","article-title":"A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines","volume":"15","author":"Lee","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.celrep.2024.114530_bib73","article-title":"Simulation-Driven Design of Stabilized SARS-CoV-2 Spike S2 Immunogens","author":"Nuqui","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.114530_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109929","article-title":"Stabilized coronavirus spike stem elicits a broadly protective antibody","volume":"37","author":"Hsieh","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114530_bib75","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41422-022-00746-3","article-title":"A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein","volume":"32","author":"Pang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2024.114530_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104341","article-title":"Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses","volume":"86","author":"Halfmann","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2024.114530_bib77","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2023.02.005","article-title":"Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease","volume":"56","author":"Zhou","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.114530_bib78","doi-asserted-by":"crossref","first-page":"eabn3715","DOI":"10.1126\/scitranslmed.abn3715","article-title":"SARS-CoV-2 S2\u2013targeted vaccination elicits broadly neutralizing antibodies","volume":"14","author":"Ng","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.114530_bib79","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41586-021-03925-1","article-title":"Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies","volume":"598","author":"Lempp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib80","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.abq0203","article-title":"Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines","volume":"377","author":"Bowen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114530_bib81","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06487-6","article-title":"Neutralization, effector function and immune imprinting of Omicron variants","volume":"621","author":"Addetia","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112621","article-title":"Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail","volume":"42","author":"Addetia","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114530_bib83","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41586-022-05513-3","article-title":"Close relatives of MERS-CoV in bats use ACE2 as their functional receptors","volume":"612","author":"Xiong","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114530_bib84","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1128\/JVI.02519-09","article-title":"Acquisition of complement resistance through incorporation of CD55\/decay-accelerating factor into viral particles bearing baculovirus GP64","volume":"84","author":"Kaname","year":"2010","journal-title":"J.\u00a0Virol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724008593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724008593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T23:14:28Z","timestamp":1760224468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724008593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2211124724008593"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114530","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.31.586409","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114530"}}